
    
      This study is open-label parallel trial with 4 weeks treatment with slow-release melatonin
      (Circadin) or with clonazepam (Rivotril).

      Polysomnography, symptom diary and questionnaire (Clinical Global Impression, RBDQ-HK, PSQI,
      ESS, SSS, ISI, BDI-II) will be performed before and after 4 weeks of each medications.
    
  